...
首页> 外文期刊>Heart failure clinics >Percutaneous Intervention for Mitral Regurgitation
【24h】

Percutaneous Intervention for Mitral Regurgitation

机译:经皮介入治疗二尖瓣反流

获取原文
获取原文并翻译 | 示例
           

摘要

Percutaneous treatment of mitral regurgitation (MR) is a promising alternative for patients with functional MR (FMR) who are not appropriate for surgery and are not responding to optimal medical therapy and cardiac resynchronization therapy. Unlike degenerative MR, where repair therapy is clearly preferred, the optimal approach for FMR has not been defined. Challenges for novel mitral repair devices are to demonstrate safety and superior efficacy to medical management in higher risk patients. Transcatheter mitral valve replacement is emerging as a feasible therapy, but requires significant additional clinical trials to define its place in treating heart failure related to MR.
机译:对于不适合手术且对最佳药物治疗和心脏再同步治疗无反应的功能性MR(FMR)患者,经皮二尖瓣关闭不全(MR)治疗是一种有前途的选择。与变性MR不同,在变性MR中显然首选修复疗法,而对于FMR的最佳方法尚未确定。新型二尖瓣修复设备面临的挑战是证明对高风险患者的医疗管理具有安全性和出色的功效。经导管二尖瓣置换术正在作为一种可行的治疗方法出现,但需要大量的额外临床试验来确定其在治疗与MR相关的心力衰竭中的地位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号